Attached files
| file | filename |
|---|---|
| EX-10.7 - EX-10.7 - Neuronetics, Inc. | stim-ex107_215.htm |
| EX-32.2 - EX-32.2 - Neuronetics, Inc. | stim-ex322_8.htm |
| EX-31.2 - EX-31.2 - Neuronetics, Inc. | stim-ex312_7.htm |
| EX-31.1 - EX-31.1 - Neuronetics, Inc. | stim-ex311_9.htm |
| EX-10.8 - EX-10.8 - Neuronetics, Inc. | stim-ex108_214.htm |
| EX-10.6 - EX-10.6 - Neuronetics, Inc. | stim-ex106_216.htm |
| EX-10.5 - EX-10.5 - Neuronetics, Inc. | stim-ex105_217.htm |
| EX-10.4 - EX-10.4 - Neuronetics, Inc. | stim-ex104_218.htm |
| EX-10.3 - EX-10.3 - Neuronetics, Inc. | stim-ex103_80.htm |
| EX-10.2 - EX-10.2 - Neuronetics, Inc. | stim-ex102_219.htm |
| 10-Q - 10-Q - Neuronetics, Inc. | stim-10q_20200630.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Neuronetics, Inc. (the “Company”) for the fiscal quarter ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: August 4, 2020 |
By: |
|
/s/ Keith J. Sullivan |
|
|
Name: |
|
Keith J. Sullivan |
|
|
Title: |
|
President and Chief Executive Officer(Principal Executive Officer)
|